The headquarters campus of Eli Lilly and Company in Indianapolis, Ind., on March 17, 2024. Scott Olson/Getty Images
Pharmaceutical giant Eli Lilly and Company on May 6 announced it would invest an additional $4.5 billion in its manufacturing sites in Lebanon, Indiana.
Indianapolis, Indiana-based Lilly said in a statement that its evolving drug pipeline and increasing demand for existing medicines spurred the additional capital commitment. Its newest facility, Lilly Lebanon Advanced Therapies, opened on the same day and will support clinical and commercial production of advanced therapies targeting genetic diseases, from initial research to commercial production.
